id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S3072 R4704 |
Duricova, 2019 | Low birth weight (weight < 2500g) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, disease free | Adjustment: No | 2.96 [0.30;29.13] C | 3/72 1/69 | 4 | 72 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3066 R4669 |
Chaparro, 2018 | Low birth weight (<2,500 mg) | 3 months (or more) before pregnancy or during pregnancy excluded | retrospective cohort | unexposed, sick | Adjustment: No |
1.61 [0.99;2.62] C excluded (exposition period) |
41/388 31/453 | 72 | 388 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3123 R4857 |
De Lima, 2018 | Low birth weight (NOS) | at least 1st trimester | prospective cohort | exposed to other treatment, sick | Adjustment: No | 0.79 [0.01;43.11] C | 0/15 0/12 | 0 | 15 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4098 R8759 |
Carman - Etanercept (Controls unexposed, disease free), 2017 | Birth weight <2500 g | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, disease free excluded | Adjustment: No |
2.20 [1.41;3.44] C excluded (control group) |
31/217 76/1,081 | 107 | 217 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4099 R8774 |
Carman - Etanercept (Controls unexposed, sick), 2017 | Birth weight <2500 g | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, sick | Adjustment: No | 1.71 [1.14;2.58] C | 31/217 172/1,940 | 203 | 217 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4106 R8799 |
Chambers - Adalimumab (Controls unexposed, sick, ADA only), 2017 | Birth weight (≤10th centile) | at least 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 0.73 [0.33;1.62] | -/- -/- | - | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3070 R4686 |
De Lima (Controls unexposed, disease free), 2016 | Low birth weight (birth weight lower than 2500 g) | 1st and 2nd trimester | prospective cohort | unexposed, disease free excluded | Adjustment: No |
2.85 [1.26;6.46] C excluded (control group) |
8/83 29/804 | 37 | 83 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3071 R4695 |
De Lima (Treatment stopped during pregnancy, sick), 2016 | Low birth weight (birth weight lower than 2500 g) | 1st and 2nd trimester | prospective cohort | unexposed, sick | Adjustment: No | 0.95 [0.21;4.29] C | 3/32 5/51 | 8 | 32 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13735 R53499 |
Komoto, 2016 | Low birth weight (<2500G) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No | 0.97 [0.24;3.95] C | 4/17 7/29 | 11 | 17 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2888 R4119 |
Weber-Schoendorfer, 2015 | Low birth weight (<2500 g) | 1st trimester | prospective cohort | unexposed, disease free | Adjustment: No | 13.45 [7.36;24.59] C | 51/399 14/1,299 | 65 | 399 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3037 R4571 |
Seirafi, 2014 | Low birth weight (< 2500 g) | 3 months (or more) before pregnancy or during pregnancy excluded | retrospective cohort | unexposed, sick | Adjustment: No before conception and/or during pregnancy |
1.73 [0.74;4.02] C excluded (exposition period) |
19/118 9/90 | 28 | 118 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3017 R4515 |
Schnitzler (Controls unexposed, disease free), 2011 | Low birth weight (<2500g) | 3 months (or more) before pregnancy or during pregnancy | prospective cohort | unexposed, disease free excluded | Adjustment: No before conception and/or during pregnancy |
1.98 [0.55;7.16] C excluded (control group) |
6/32 5/48 | 11 | 32 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3018 R4520 |
Schnitzler (Unexposed control, sick), 2011 | Low birth weight (<2500g) | 3 months (or more) before pregnancy or during pregnancy excluded | prospective cohort | unexposed, sick | Adjustment: No before conception and/or during pregnancy |
1.44 [0.46;4.46] C excluded (exposition period) |
6/32 9/65 | 15 | 32 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 7 studies | 1.86 [0.66;5.25] | 291 | 752 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick; 2: Controls unexposed, sick, ADA only; 3: Treatment stopped during pregnancy, sick;
Asymetry test p-value = 0.7121 (by Egger's regression)
slope=1.1323 (0.8028); intercept=-0.7861 (2.0119); t=0.3907; p=0.7121
excluded 3017, 3070, 4098